The pharma commercialization services sector is benefiting from a powerful set of structural tailwinds—including a replenished drug development pipeline, growing complexity of novel modalities, and greater adoption of AI-driven commercialization tools—all of which are creating robust and sustained demand for third-party commercialization expertise.
Across the food and beverage sector, the shift toward natural ingredients is a powerful influence on product development, supply chains, and competitive dynamics. As consumers, retailers, and restaurant chains seek higher-quality, natural, and clean-label items, leading natural ingredient companies will continue to benefit. Here, our Consumer Group shares the themes creating demand for natural ingredients and what several recent clients reveal for today’s investors.
Within the growing and resilient food sector, specialty distributors have a prominent place at the table—delivering immense value to their customers while giving investors access to appealing themes. Below, our Consumer Group shares why specialty food distribution is seeing strong M&A activity and several recent Harris Williams engagements that highlight the opportunity.
A wide range of infrastructure-focused businesses are seeing strong long-term demand tied to electrification, grid resiliency, regulatory enforcement, and asset renewal. That’s creating a steady stream of opportunities for today’s investors across power systems, utility services, environmental infrastructure, specialty industrial components, engineering, roadway infrastructure, water/wastewater, and test, inspection, and certification. And while AI is meaningfully improving efficiency, safety, and asset productivity across this ecosystem, it is generally not impacting core business models, revenue durability, or growth drivers. In fact, the sector’s insulation against AI disruptions makes it more appealing to investors than ever.
In a world being transformed by AI, a wide range of industrials sectors continue to provide investors with durable opportunities to deploy capital and achieve reliable returns. In particular, HALO businesses—defined by heavy assets and low obsolescence—operate at the physical foundation of the economy, producing materials, components, and systems that are required regardless of software advancement or digital substitution.
The pharma logistics sector is capturing strong investor attention as it becomes indispensable to modern healthcare delivery. “The pharma logistics ecosystem is the backbone of global healthcare, where operational precision and specialized handling expertise are vital for both treatment efficacy and asset value preservation,” says Cheairs Porter, a managing director.
Across healthcare, life sciences, industrials, infrastructure, and other highly regulated environments, organizations are increasingly reliant on software platforms that operationalize compliance, audit readiness, and risk management as core operating infrastructure.
For founders and family‑owned businesses considering a sale—especially to a strategic buyer—the emotional, operational, and legacy‑related implications can be just as complex as the financial ones.
Featuring resilient and recurring demand, a wide variety of engineered equipment, products, and components are on investors’ radar. While many categories are seeing success, companies specializing in building automation and controls are particularly appealing.
Organizations and consumers are both seeking ways to maintain cleanliness and safety, driving sustained demand for many types of products. At the intersection of the health and hygiene and janitorial and sanitation categories sits our recent client GOJO Industries. The company’s well-known PURELL® brand plays a unique and essential role in the daily lives of millions of people, whether in healthcare settings, at the workplace, in the businesses they frequent as customers, or in the home.
